HOME >> BIOLOGY >> NEWS
Middle-aged women who consume many fruits and vegetables are at much lower risk of cardiovascular disease

Significant reductions in cardiovascular disease (CVD) risk - by as much as one-half in some cases - can be achieved by consumption of a diet high in fruits and vegetables, according to a study published in the current issue of The American Journal of Clinical Nutrition. Liu et al. assessed a large group of middle-aged female health professionals for fruit and vegetable intake and subsequently followed them over a 5-year period for instances of CVD. They found that those women who consumed the largest amounts of fruits and vegetables (10 or more servings per day) attained a correspondingly greater reduction in disease risk. When the dietary analysis excluded women with a history of high risk conditions such as diabetes, hypertension and hypercholesterolemia, risk reduction was even more pronounced. Across all of the more elevated levels of fruit and vegetable consumption - anywhere from 4 to 10 servings per day - overall reduction in CVD risk was approximately 20-30%. An editorial accompanying the study suggests that plant foods may be beneficial in human disease not only because of the nutrients they contain, but because of inherent substances that help regulate plant metabolism.

The authors analyzed prospective data from the Women's Health Study of 39,876 middle-aged nurses with no previous history of CVD. In 1993 the participants completed a detailed food-frequency questionnaire and were subsequently followed for an average of 5 years for incidence of nonfatal myocardial infarction, stroke, coronary angioplasty, coronary bypass or death due to CVD. After the researchers divided the participants into groups or levels according to the number of daily servings of fruits and vegetables, a strong inverse association was evident between total fruit and vegetable intake and relative risk of CVD. Those who consumed 10 or more servings per day were at 32% lower risk of CVD than those who consumed one serving. The overall observed CVD risk in those women who ate
'"/>

Contact: Beth Wettergreen
bmwettergreen@ucdavis.edu
530-754-7528
American Journal of Clinical Nutrition
19-Sep-2000


Page: 1 2

Related biology news :

1. Far more men than women favor routine paternity testing at birth
2. Folic acid vitamin use by women reaches all-time high, March of Dimes survey finds
3. Alcohol-use and depression among pregnant and postpartum women
4. More aggressive breast cancer tumors found in African American women
5. New study confirms process leading to disorder causing male characteristics in women
6. Gestational diabetes not found to alter the metabolic processes in obese pregnant women
7. Why lung cancer in women is different from men
8. With fat, women have a more visceral response
9. NASA-inspired technology may help preserve womens future fertility after cancer treatment
10. New research finds summer-born women have fewer children
11. New studies show Curves Program raises metabolic rate in overweight and sedentary women

Post Your Comments:
(Date:8/11/2015)... August 11, 2015 Today, ZUK announced its ... as well as expected revenues in 2015 that relate to sales ... revenue guidance of approximately 2,200 MSEK for 2015. Jörgen ... prominent smartphone manufacturer in China ... selected FPC1 155 for Z1 ...
(Date:8/6/2015)... Germany , August 6, 2015 ... (SMI) shows the world,s first Eye Tracking ... Epson,s Moverio BT-200 see-through head mounted display and on ... unprecedented quality and efficiency is brought to personalized visualization ... the first time, professionals and researchers can integrate gaze, ...
(Date:8/5/2015)... , Aug. 5, 2015 The biosensors market ... in applications, penetration into newer sectors, and development of ... global biosensors space has seen the entry of multiple ... so far. (Photo - http://photos.prnewswire.com/prnh/20150805/255570 ) ... Analysis of the Global Biosensors Market ( ...
Breaking Biology News(10 mins):FPC's Touch Fingerprint Sensor FPC1155 in ZUK's Smartphone Z1 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 3Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4
(Date:8/31/2015)... , Aug. 31, 2015  For people with Down ... their day. The biotechnology company, located in the Science ... of the best potential therapies yet for people with Down ... " Correction of Down syndrome and Edwards syndrome aneuploidies ... DNA Research . Elixirgen plans to develop this ...
(Date:8/31/2015)... 31, 2015 FLX Bio, Inc., a biopharmaceutical ... cancer immunotherapies, announced today that it has appointed ... and William Ho , M.D., Ph.D., as Chief ... management team led by veterans of Flexus Biosciences, Inc., ... Scientific Officer; Jay Powers , Ph.D., Vice President, ...
(Date:8/31/2015)... ... August 31, 2015 , ... There’s a new treatment option for excessive menstrual ... available new FDA approved system in the last 14 years, and the only endometrial ... (zero bleeding) rate of 66%, the high Patient Satisfaction rate of 98%, and the ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... presented two studies at the International Spine Intervention Society’ s 23rd ... through to August 1st, 2015. With a focus on evidence-based research and clinical ...
Breaking Biology Technology:New Down syndrome therapy discovered 2FLX Bio Announces Senior Management Hires and Initiation of Phase 1 Trial of FLX925 2FLX Bio Announces Senior Management Hires and Initiation of Phase 1 Trial of FLX925 3FLX Bio Announces Senior Management Hires and Initiation of Phase 1 Trial of FLX925 4U.S. FDA Approves Minerva Endometrial Ablation System 2U.S. FDA Approves Minerva Endometrial Ablation System 3Proove Biosciences Presents New Research Study at the International Spine Intervention Society’s Annual Scientific Meeting 2Proove Biosciences Presents New Research Study at the International Spine Intervention Society’s Annual Scientific Meeting 3Proove Biosciences Presents New Research Study at the International Spine Intervention Society’s Annual Scientific Meeting 4
Cached News: